Clinical Specialties & Imaging

Overjet Image Enhancement Assist is an FDA-cleared AI tool that enhances the clarity of dental radiographs by reducing noise and improving contrast and sharpness, aiding in more confident diagnoses and improved patient communication.

Overjet Iris is an FDA-cleared AI-powered dental imaging system that enhances X-ray quality, provides real-time AI analysis for diagnostics, and improves patient communication through visual aids.

Overjet Periapical Radiolucency Assist is an FDA-cleared AI tool that aids dentists in detecting and segmenting periapical radiolucencies on X-rays, enhancing diagnostic accuracy and patient communication.

Owkin develops AI solutions for drug discovery and real-world evidence, leveraging federated learning across hospital networks to accelerate biomedical research and clinical insights.

Oxipit ChestLink is the world's first CE Class IIb-certified autonomous AI application for healthy chest X-ray reporting, capable of identifying normal studies with 99.9% sensitivity. It automates the reporting of normal chest X-rays, reducing radiologist workload and improving efficiency.

AI-powered applications that aid in the detection and grading of prostate cancer on H&E-stained whole-slide images of prostate needle biopsies.

The PAPNET Testing System by Neuromedical Systems was an early AI-powered device that used neural networks to semi-automate the re-screening of conventional Pap smears, flagging suspicious cells for human review to enhance cervical cancer detection.

Proprio’s FDA-cleared, award-winning navigation platform, Paradigm, uses advanced sensors, compute, and AI to capture multi-modal surgical views and build a real-time 3D model of anatomy, improving precision and streamlining workflows.

The Pathwork Tissue of Origin Test is an FDA-cleared molecular diagnostic test that uses AI-powered gene expression profiling to help identify the primary site of challenging cancers, aiding oncologists in treatment decisions.

A molecular diagnostic test that uses microarray-based RNA profiling and a machine learning algorithm to help pinpoint the origin of hard-to-identify tumors, aiding physicians in optimizing cancer therapies.

Cardiosense's FDA-cleared AI tool noninvasively estimates pulmonary capillary wedge pressure (PCWP) using a wearable sensor, providing real-time insights for proactive heart failure management.

Pearl Second Opinion® offers FDA-cleared AI for 2D and 3D dental X-ray analysis, assisting in the detection of pathologies like caries, calculus, bone loss, and periapical radiolucencies, leading to improved diagnostic accuracy and patient trust.

PeekMed web is an AI-powered, web-based preoperative planning software for orthopedic surgery, offering automatic segmentation, landmark detection, and surgical planning to enhance precision and efficiency.

The Peerbridge Cor™ System is an FDA-cleared, AI-enabled ambulatory ECG system that combines a wearable patch with a cloud-based platform to provide high-fidelity cardiac diagnostics and monitoring for up to 7 days. It offers advanced insights for conditions like arrhythmias, heart failure, and sleep apnea, aiming for earlier detection and improved patient outcomes.

PeriCALM Patterns by PeriGen is an AI-powered software for fetal/maternal monitoring, using advanced algorithms to detect and label fetal heart rate patterns and uterine contractions, providing clinical decision support and integrating with EHR systems to enhance perinatal care.